Followers | 283 |
Posts | 1162 |
Boards Moderated | 0 |
Alias Born | 10/04/2020 |
Sunday, July 25, 2021 12:28:49 PM
Like I've said many times before "mRNA based Pharmaceuticals are The Future Of Medicine."
This is unequivocally UNDENIABLE!!
A) It represents The Greatest THRUST in Modern Medical Science which is precisely what many of RGBP's Patents are based on!
B) It is also what Kite Pharma's Patent was based on who got bought out by Gilead Sciences in 2017 for $11.9 BILLION CASH!!!
C) It by far has a $Trillion Dollar Market Capacity!
Believe it or not, it has the potential to:
#1- CURE various Cancers
#2- Reduce many if not most cancers to non-lethal
#3- Eliminate the possibility of acquiring Cancer altogether
Many people don't realize that Innovations & Discoveries in modern day society are increasing EXPOENTIALLY!!! This too is undeniable!
In a recent post I listed the names of various medical scientists that were recruited by Regen Biopharma some years ago who contributed to the development of many of RGBP's Patents.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165082217
One of those scientists, Dr. Boris Minev, is an Immunologist-Oncologist who developed the FIRST CANCER VACCINE known in world history.
Before coming to Regen BioPhrma he was a Principal Investigator at The Laboratory of Tumor Immunology & Immunotherapy at The Moores Cancer Center UC San Diego where he worked extensively on discovery of Cancer Vaccines.
He is the first medical scientist to develop a Tumor Vaccine "Melacine" approved by a regulatory body:
https://calidibio.com/our-company/our-team/boris-minev-md/
https://database.inahta.org/article/1056
This Tumor Vaccine-Melacine was found to have success in treating Late Stage Melanomas (Stage 4), thereby preventing the progression of this deadly cancer.
An amazing Pharmaceutical Innovation given the fact that nearly 100% of all Stage 4 Melanoma patents die within 12 months.
Be well and prosper...
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM